Evidence map›Paper›PMID 36478752›Full record

ArticleEuropean stroke journal2022

High thrombus platelet content is associated with a lower rate of first pass effect in stroke treated by endovascular therapy.

François Delvoye, Lucas Di Meglio, Arturo Consoli, Mialitiana Solo Nomenjanahary, Sébastien Dupont, Julien Labreuche, Benjamin Maier, Michel Piotin, Raphael Blanc, Simon Escalard and 12 more

Open access · greenAbstract read
In one paragraph

Article in European stroke journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. The use of the NeVa stent-retriever for bail-out mechanical thrombectomy.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025
    Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 2 countries.

François DelvoyeInterventional Neuroradiology Department and Biological Resources Center, Rothschild Foundation Hospital, Paris, France.ORCID https://orcid.org/0000-0002-0697-2156
Lucas Di MeglioInterventional Neuroradiology Department and Biological Resources Center, Rothschild Foundation Hospital, Paris, France.
Arturo ConsoliInterventional Neuroradiology Department, Hopital Foch, Suresnes, France.
Mialitiana Solo NomenjanaharyLaboratory of Vascular Translational Science, U1148 INSERM, Université de Paris, Paris, France.
Sébastien DupontLaboratory of Vascular Translational Science, U1148 INSERM, Université de Paris, Paris, France.
Julien LabreucheDepartment of Biostatistics, CHU Lille, Lille, France.
Benjamin MaierInterventional Neuroradiology Department and Biological Resources Center, Rothschild Foundation Hospital, Paris, France.
Michel PiotinInterventional Neuroradiology Department and Biological Resources Center, Rothschild Foundation Hospital, Paris, France.
Raphael BlancInterventional Neuroradiology Department and Biological Resources Center, Rothschild Foundation Hospital, Paris, France.
Simon EscalardInterventional Neuroradiology Department and Biological Resources Center, Rothschild Foundation Hospital, Paris, France.
Perrine BoursinInterventional Neuroradiology Department and Biological Resources Center, Rothschild Foundation Hospital, Paris, France.
Mylène HamdaniInterventional Neuroradiology Department and Biological Resources Center, Rothschild Foundation Hospital, Paris, France.
Hocine RedjemInterventional Neuroradiology Department and Biological Resources Center, Rothschild Foundation Hospital, Paris, France.
Stanislas SmajdaInterventional Neuroradiology Department and Biological Resources Center, Rothschild Foundation Hospital, Paris, France.
Solène HébertInterventional Neuroradiology Department and Biological Resources Center, Rothschild Foundation Hospital, Paris, France.
Candice SabbenDepartment of Neurology, Rothschild Foundation Hospital, Paris, France.
Alain Maertens de NoordhoutUniversity of Liege, Liège, Belgium.
Martine Jandrot-PerrusLaboratory of Vascular Translational Science, U1148 INSERM, Université de Paris, Paris, France.
Bertrand LapergueDepartment of Neurology, Hopital Foch, Suresnes, France.
Mikael MazighiInterventional Neuroradiology Department and Biological Resources Center, Rothschild Foundation Hospital, Paris, France.
Benoit Ho-Tin-NoéLaboratory of Vascular Translational Science, U1148 INSERM, Université de Paris, Paris, France.
Jean-Philippe DesillesInterventional Neuroradiology Department and Biological Resources Center, Rothschild Foundation Hospital, Paris, France.
Inserm · FRFondation de Rothschild · FRHôpital Foch · FRUniversity of Liège · BECentre Hospitalier Universitaire de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: First pass effect (FPE), the occurrence of complete reperfusion after one pass with no rescue attempt during endovascular therapy (EVT), is associated with the best clinical outcome after an acute ischemic stroke (AIS). Previous studies evaluating FPE occurrence according to EVT technical strategies, occlusion locations, or thrombus composition have provided controversial results. Here, we performed a correlation analysis between FPE occurrence and AIS thrombus cellular composition, as assessed using quantitative biochemical assays. Patients and methods: Homogenates of AIS thrombi from 250 patients were prepared by mechanical grinding. Platelet, red blood cell (RBC), and leukocyte contents of AIS thrombi were respectively estimated by quantification of GP (glycoprotein) VI, heme, and DNA in thrombus homogenates. FPE was defined as a modified Thrombolysis in Cerebral Infraction (mTICI) score of 2C or 3 after a single EVT device pass. Results: AIS thrombi successfully removed after a single pass were poorer in GPVI (0.098 ± 0.023 vs 0.111 ± 0.024 ng/mg, Discussion and conclusion: Thrombus platelet content may hamper thrombus removal by EVT. This result suggests that adjunctive therapies or functionalization of retrieval devices targeting platelets may improve EVT efficacy.

Indexed as

biomarkerendovascular therapyfirst pass effectPlateletsthrombosis

Identifiers

PMID36478752
PMCPMC9720861
OpenAlexW4288050603

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.